home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zoetis (NY:ZTS)

78.78 -0.92 (-1.16%)

Streaming Delayed Price Updated: 1:02 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

25 26 Next >

Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today ↗

March 19, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Looking Into Zoetis's Recent Short Interest ↗

March 08, 2024

Via Benzinga

Zoetis to Participate in the Barclays Global Healthcare Conference

March 05, 2024

From Zoetis Inc.

Via Business Wire

1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now ↗

February 26, 2024

Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.

Via The Motley Fool

Topics Stocks

4 Analysts Have This To Say About Zoetis ↗

February 20, 2024

Via Benzinga

(ZTS) - Analyzing Zoetis's Short Interest ↗

February 14, 2024

Via Benzinga

Is ZOETIS INC (NYSE:ZTS) a Strong Candidate for Quality Investing? ↗

February 12, 2024

Why Quality Investors Should Delve into ZOETIS INC (NYSE:ZTS) for Investment Opportunities.

Via Chartmill

Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit

February 21, 2024

From Zoetis Inc.

Via Business Wire

Zoetis (ZTS) Q4 2023 Earnings Call Transcript ↗

February 13, 2024

ZTS earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What's Driving Markets Tuesday? ↗

February 13, 2024

Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as stocks were hit by the impact of a higher-than-expected inflation report.

Via Benzinga

Topics Economy Stocks

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today ↗

February 01, 2024

Via Benzinga

What 4 Analyst Ratings Have To Say About Zoetis ↗

January 17, 2024

Via Benzinga

Will ZOETIS INC Break Out? A Technical Analysis Perspective. ↗

January 16, 2024

ZOETIS INC (NYSE:ZTS) has a strong technical rating of 10 out of 10, indicating a potential breakout.

Via Chartmill

Animal Health-Focused Zoetis Stock Faces Near-Term Pressure, Analyst Cites Uncertainty In Q4 Results, Weak Margins ↗

February 13, 2024

Zoetis' Q4 2023 performance with $2.21 billion revenue, 8% YoY growth, and strong sales in companion animal products.

Via Benzinga

Zoetis Reports Fourth Quarter and Full Year 2023 Results

February 13, 2024

From Zoetis Inc.

Via Business Wire

Zoetis Declares Second Quarter 2024 Dividend

February 06, 2024

From Zoetis Inc.

Via Business Wire

Drug Maker AbbVie Stock Sees RS Rating Jump To 81 ↗

February 05, 2024

AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81.

Via Investor's Business Daily

$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today ↗

January 04, 2024

Via Benzinga

Peering Into Zoetis's Recent Short Interest ↗

December 29, 2023

Via Benzinga

Earnings Scheduled For February 13, 2024 ↗

February 13, 2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.

Via Benzinga

Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings ↗

February 01, 2024

Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level.

Via Investor's Business Daily

Paws And Prosperity: Exploring U.S. Pet Services Growth And The Anticipated Surge In Annual Pet Spending From $980 To $1,292 By 2025 ↗

January 30, 2024

The number of U.S. homes with pets has been trending upward for decades, with more than 5 million more pets in the U.S. than before the pandemic. Beyond the pandemic-driven boom, the trends continue,...

Via Benzinga

AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow ↗

January 24, 2024

AbbVie shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Via Investor's Business Daily

4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either ↗

January 20, 2024

These stocks never seem to go on sale. Here's why I'm buying them anyway.

Via The Motley Fool

Zoetis Wins 2024 Catalyst Award

January 18, 2024

From Zoetis Inc.

Via Business Wire

Stifel: ‘Party Is Just Getting Started’ In This Stock That's Up 80% ↗

January 07, 2024

Animal-pharma company Elanco Animal Health, once a subsidiary of Lilly, looks especially good with its new treatment for parvovirus in dogs.

Via Talk Markets

Reasonable Growth, Debt Levels, and a High ROIC Make ZOETIS INC (NYSE:ZTS) Appealing to Quality Investors. ↗

January 02, 2024

Reasonable Growth, Debt Levels, and a High ROIC Make ZOETIS INC (NYSE:ZTS) Appealing to Quality Investors.

Via Chartmill

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2023 Financial Results

December 28, 2023

From Zoetis Inc.

Via Business Wire

Pet Care Profits: 3 Stocks Benefitting from the Pet Boom ↗

December 26, 2023

These pet care stocks tap into a booming $246.66 billion market, offering unique investment stability and growth.

Via InvestorPlace

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com